Interaction of Salmonella typhi strains with cultured human monocyte-derived macrophages

D R Sizemore1, E A Elsinghorst, L C Eck

  • 1Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, USA.

Infection and Immunity
|January 1, 1997
PubMed

Insights

This study developed a primary-cell assay using human monocyte-derived macrophages (MDM) to compare Salmonella typhi virulence. The assay evaluated attenuated and wild-type strains, including the Ty21a oral vaccine, assessing their interaction and survival within MDM.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Salmonella typhi causes typhoid fever, a significant global health concern.
  • Developing effective vaccines and understanding bacterial virulence are crucial for disease control.
  • Primary cell assays offer a valuable model for studying host-pathogen interactions.

Purpose of the Study:

  • To establish a primary-cell assay using human monocyte-derived macrophages (MDM) for evaluating Salmonella typhi virulence.
  • To compare the relative virulence of novel attenuated Salmonella typhi strains against wild-type virulent strains and the existing oral vaccine strain (Ty21a).

Main Methods:

  • Isolation and culture of human monocyte-derived macrophages (MDM).
  • Infection of MDM with different Salmonella typhi strains: delta aroA143-attenuated, wild-type virulent, and Ty21a.
  • Assessment of bacterial interaction with and survival within MDM.

Main Results:

  • The primary-cell assay using MDM effectively differentiated the virulence profiles of the tested Salmonella typhi strains.
  • Differential interaction and survival rates of attenuated, wild-type, and Ty21a strains within MDM were observed.

Conclusions:

  • Human monocyte-derived macrophages (MDM) serve as a suitable model for developing a primary-cell assay to assess Salmonella typhi virulence.
  • The developed assay can aid in the characterization and comparative evaluation of novel attenuated Salmonella strains for vaccine development.

Related Concept Videos